RefluSTAT is a new product in JGL's portfolio of non-prescription drugs. Contains alginates and carbonates for a quick and efficient mechanical blockage of the return of gastric juice into the oesophagus. When the product comes into contact with the acidic pH of the stomach, sodium alginate (natural polymer extracted from brown algae) is precipitated to form a gel. Meanwhile, carbonates in the product release carbon dioxide which allows the gel to rise and form a plug which provides a physical barrier that prevents the return of gastric juice into the oesophagus.

In addition, sodium bicarbonate helps in reducing gastric acidity.

It is for the above reasons that RefluSTAT reduces symptoms such as heartburn, heartburn during pregnancy, the return of acid from the stomach into the oesophagus, indigestion, cough and irritation of the throat and pharynx quickly and efficiently.

More about RefluSTAT read HERE.

JADRAN - GALENSKI LABORATORIJ dd published this content on 25 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 25 July 2016 12:10:01 UTC.

Original documenthttp://www.jgl.hr/en/news-and-the-media/news/reflustat-–-an-antireflux-oral-suspension-in-jgl’s-portfolio/

Public permalinkhttp://www.publicnow.com/view/FD2BAE0FB1112CA851176589B14E8A8563F94FBA